Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-27

Clinical Trial Update: Effects of Amygdala Neurofeedback on Depressive Symptoms [NA]

View source ↗

Summary

A terminated clinical trial studied amygdala neurofeedback for depressive symptoms in Major Depressive Disorder; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kymberly Young | Conditions: Major Depressive Disorder | NA | Status: TERMINATED | Results posted: 2024-12-27